Welcoming a new baby into the world is a joyous occasion, but it can also bring challenges when issues arise. One such critical condition that can affect newborns is Persistent Pulmonary Hypertension of the Newborn (PPHN). This condition, which affects the transition from fetal to neonatal circulation, can lead to serious complications if not promptly diagnosed and treated.

In a healthy newborn, the circulatory system undergoes significant changes immediately after birth, adapting to life outside the womb. The lungs must take over the essential task of oxygenating the blood, and the pulmonary blood vessels should relax and open up to facilitate this process.

In infants with PPHN, this transition does not occur smoothly. The blood vessels in the lungs remain constricted, leading to high blood pressure in the lungs and preventing adequate oxygen from reaching the bloodstream.

What Is Persistent Pulmonary Hypertension Of Newborn?

Persistent Pulmonary Hypertension of Newborn (PPHN)
The doctor examines the boy in his room and the boy is playing with the toy car and eating snacks.

Persistent Pulmonary Hypertension of the Newborn (PPHN) is a serious condition where a newborn’s circulatory system fails to adapt to breathing outside the womb, resulting in high blood pressure in the lungs and insufficient oxygen in the bloodstream. Normally, after birth, the blood vessels in the lungs relax to allow for proper oxygenation, but in PPHN, these vessels remain constricted, causing blood to bypass the lungs and leading to severe hypoxemia. This condition is often linked to underlying issues such as birth asphyxia, meconium aspiration, or congenital abnormalities, and requires prompt medical intervention to ensure adequate oxygen delivery and prevent long-term complications.


The symptoms of Persistent Pulmonary Hypertension of the Newborn (PPHN) typically manifest as signs of severe respiratory distress and inadequate oxygenation.

Key symptoms include:

  • Rapid Breathing (Tachypnea): Newborns with PPHN often breathe quickly as they struggle to get enough oxygen.
  • Cyanosis: A bluish tint to the skin, lips, and nails due to low oxygen levels in the blood.
  • Grunting: A grunting sound with each breath as the baby tries to keep the airways open.
  • Flaring Nostrils: The nostrils widen with each breath, indicating difficulty in breathing.
  • Retractions: Visible sinking of the chest wall with each breath, showing increased effort to breathe.
  • Low Oxygen Levels: Despite receiving supplemental oxygen, babies with PPHN often have low oxygen saturation.
  • Lethargy or Irritability: Babies may be unusually sleepy or difficult to console due to poor oxygenation.
  • Poor Feeding: Difficulty in feeding or lack of interest in feeding due to breathing issues.


Persistent Pulmonary Hypertension of the Newborn (PPHN) can be triggered by several conditions that impede the normal transition of the circulatory system at birth.

One common cause is meconium aspiration syndrome, where a newborn inhales a mixture of meconium and amniotic fluid into the lungs, leading to inflammation and restricted blood flow. Birth asphyxia is another significant factor, where inadequate oxygen supply during labor and delivery results in sustained high pulmonary vascular resistance.

Congenital diaphragmatic hernia, a condition where abdominal organs push into the chest cavity and hinder lung development, can cause PPHN. Sepsis and pneumonia are also notable contributors, as severe infections can provoke inflammatory responses and pulmonary hypertension.

Maternal factors like the use of nonsteroidal anti-inflammatory drugs (NSAIDs) during pregnancy have been linked to the development of PPHN. Idiopathic cases, where the exact cause is unknown, also occur, highlighting the complexity and multifactorial nature of this condition.

What Are The Risk Factors For PPHN?

Several risk factors for Persistent Pulmonary Hypertension of the Newborn (PPHN), a condition characterized by high blood pressure in the lungs and inadequate oxygenation of the blood.

Maternal factors play a crucial role, with certain conditions during pregnancy increasing the likelihood of PPHN in newborns. Maternal use of selective serotonin reuptake inhibitors (SSRIs), a class of antidepressant medications, has elevated risk of PPHN in newborns. Gestational diabetes, preeclampsia, and oligohydramnios (reduced amniotic fluid) have been identified as maternal risk factors for PPHN.

Other risk factors include prematurity, perinatal asphyxia, and respiratory distress syndrome. Infants born via cesarean section may also face an increased risk of PPHN compared to those born vaginally. Understanding these risk factors is crucial for early identification and intervention to improve outcomes for affected newborns.

What Are The Long-Term Effects Of PPHN?

Persistent Pulmonary Hypertension of Newborn (PPHN)
A newborn baby is spending his time with his father and enjoying.

The long-term effects of Persistent Pulmonary Hypertension of the Newborn (PPHN) can vary depending on several factors, including the severity of the condition, the underlying causes, and the effectiveness of treatment. Many infants with PPHN respond well to prompt intervention and recover without long-term consequences, others experience lingering respiratory issues or developmental challenges.

Respiratory Complications: Some infants may continue to experience respiratory problems, such as chronic lung disease or asthma, later in childhood. PPHN can cause damage to the delicate lung tissues, leading to impaired lung function and susceptibility to respiratory infections.

Neurodevelopmental Impairments: Severe cases of PPHN, especially those associated with birth asphyxia or prolonged hypoxemia, can result in neurological complications. These may include developmental delays, cognitive impairments, or neurological disabilities such as cerebral palsy.

Pulmonary Hypertension: PPHN typically resolves with appropriate treatment, there is a risk of developing pulmonary hypertension later in life. Involves high blood pressure in the arteries of the lungs and can lead to progressive heart failure if left untreated.

Psychological and Emotional Impact: Prolonged hospitalization or invasive treatments such as mechanical ventilation or extracorporeal membrane oxygenation (ECMO), can also have psychological and emotional repercussions for both the child and their family. Anxiety, post-traumatic stress disorder (PTSD), and challenges in bonding and attachment may arise as a result.

Diagnosis And Tests

Diagnosing Persistent Pulmonary Hypertension in Newborns (PPHN) requires a combination of clinical evaluation, imaging studies, and laboratory tests to assess the severity and identify any causes.

Key Components Of The Diagnostic Process

1. Clinical Evaluation: Healthcare providers will conduct a full checkup of the newborn, paying close attention to signs of respiratory distress, cyanosis, and abnormal breathing patterns such as grunting or flaring nostrils. The medical history, including pregnancy, labor, and delivery, may also provide valuable insights into potential risk factors for PPHN.

2. Blood Gas Analysis: Arterial blood gas (ABG) analysis is essential for assessing oxygenation and acid-base balance in infants suspected of PPHN. It helps determine the severity of hypoxemia and respiratory acidosis, guiding treatment decisions.

3. Echocardiography: Transthoracic echocardiography is a non-invasive imaging technique that allows to visualize the structure and function of the heart and pulmonary vasculature. It is the primary diagnostic tool for confirming the presence of pulmonary hypertension and assessing right ventricular function and congenital heart defects.

4. Chest X-ray: A chest X-ray evaluates lung parenchyma, assesses lung expansion, and identifies signs of pulmonary edema or lung pathology. (meconium aspiration syndrome or pneumonia)

5. Laboratory Tests: laboratory tests are conducted to assess for causes of PPHN, such as sepsis, metabolic disorders, or congenital anomalies. These tests may include complete blood count (CBC), blood cultures, serum electrolytes, and metabolic panels.

6. Pulse Oximetry: Pulse oximetry is essential for assessing the effectiveness of oxygen therapy and ensuring adequate oxygen delivery to the tissues.

7. Other Diagnostic Modalities: Such as CT scans, MRI, or ventilation-perfusion (V/Q) scans, to evaluate lung function and other conditions.

Management And Treatment

Persistent Pulmonary Hypertension of Newborn
The doctor checks the baby for any health problems and breathing normally or not.

The management and treatment of PPHN require a multidisciplinary approach involving neonatologists, pediatric cardiologists, respiratory therapists, and other healthcare professionals. The primary goals improve oxygenation, reduce pulmonary vascular resistance, and support cardiovascular function by addressing causes or complications.

Key Components Of PPHN Management

Oxygen Therapy: Supplemental oxygen is the cornerstone of PPHN treatment, aimed at correcting hypoxemia and improving tissue oxygenation. High-concentrated oxygen is administered via mechanical ventilation to maintain arterial oxygen saturation minimizing the oxygen toxicity.

Mechanical Ventilation: Severe respiratory distress or persistent hypoxemia requires mechanical ventilation to support gas exchange and reduce the work of breathing. Ventilatory strategies include conventional ventilation, high-frequency oscillatory ventilation (HFOV), or continuous positive airway pressure (CPAP).

Inhaled Nitric Oxide (iNO): Inhaled nitric oxide is a potent pulmonary vasodilator that dilates the pulmonary vasculature, improving oxygenation and reducing pulmonary artery pressure in infants. A specialized delivery system is typically initiated in a monitored setting, like the neonatal intensive care unit (NICU).

Extracorporeal Membrane Oxygenation (ECMO): For infants with refractory hypoxemia or cardiovascular instability despite maximal medical therapy, ECMO is a life-saving intervention. ECMO provides temporary cardiac and respiratory support by bypassing the heart and lungs, allowing for gas exchange and oxygen delivery.

Fluid and Electrolyte Management: Optimal fluid balance and electrolyte management maintain hemodynamic stability and prevent fluid overload or dehydration. Close monitoring of fluid intake and output, and serum electrolyte levels prevents complications such as hyponatremia or hyperkalemia.

Pharmacological Therapy: Pharmacological agents are used to reduce pulmonary vascular resistance and improve oxygenation in infants with PPHN. Include pulmonary vasodilators such as sildenafil, milrinone, or prostaglandins, administered intravenously as adjunctive therapy.

Nutritional Support: Adequate nutrition is essential for infants with PPHN to support growth and development while minimizing metabolic demands. Enteral or parenteral nutrition may be needed, with close monitoring of caloric intake, fluid balance, and electrolyte status.

Underlying Cause Management: Identifying and addressing any underlying causes or contributing factors for PPHN is essential for optimizing outcomes. This may involve treating underlying infections, correcting metabolic abnormalities, or surgically repairing congenital anomalies such as congenital diaphragmatic hernia.

What Is The Recovery Time For PPHN?

The recovery time for Persistent Pulmonary Hypertension of the Newborn (PPHN) depends on several factors. Including the severity of the condition, the effectiveness of treatment, and the presence of any underlying health issues. Infants with PPHN show improvement within days to weeks after initiation of treatment, with resolution of respiratory distress and normalization of oxygenation.

Infants who respond well to initial therapies such as oxygen supplementation, mechanical ventilation, and inhaled nitric oxide may experience rapid improvement in symptoms and lung function. Some infants may require a longer duration of respiratory support or additional interventions such as extracorporeal membrane oxygenation (ECMO) for refractory cases, which can extend the recovery period.

For infants with milder forms of PPHN or those without significant underlying health issues, recovery may be quicker. With resolution of symptoms and normalization of lung function within a few days to weeks. PPHN is associated with severe lung injury, congenital anomalies, or neurological complications. The recovery process is more prolonged, and long-term respiratory or developmental issues may persist.

What Is The Survival Rate Of PPHN?

Persistent Pulmonary Hypertension of Newborn
The young girl is in a hospital bed with her guardian and she is ill, getting treatment.

The survival rate of PPHN has improved in recent years due to advances in neonatal care and treatment modalities. With prompt diagnosis and appropriate management, the majority of infants with PPHN can expect a favorable outcome. The survival rate depends on factors such as the severity of the condition, and the effectiveness of treatment.

The survival rate for infants with PPHN ranges from approximately 70% to 90%. With higher rates observed in centers with specialized neonatal intensive care units (NICUs) inhaled nitric oxide (iNO) and extracorporeal membrane oxygenation (ECMO). Close monitoring, timely intervention, and multidisciplinary care are essential for optimizing survival and reducing the risk in infants with PPHN.

Frequently Asked Questions (FAQs)

What is Persistent Pulmonary Hypertension of the Newborn (PPHN)?

PPHN is a serious condition in newborns where the circulatory system fails to adapt to breathing outside the womb, leading to high blood pressure in the lungs and inadequate oxygenation of the blood.

What Causes PPHN?

PPHN is caused, by birth asphyxia, meconium aspiration syndrome, congenital diaphragmatic hernia, infections, maternal use of certain medications, and idiopathic factors.

What are the symptoms of PPHN?

Symptoms of PPHN include rapid breathing (tachypnea), cyanosis (bluish skin color), grunting, flaring nostrils, respiratory distress, low oxygen levels, lethargy, and poor feeding.

How is PPHN diagnosed?

Diagnosis of PPHN by clinical evaluation, blood gas analysis, echocardiography, chest X-ray, and other laboratory tests to assess oxygenation, and pulmonary pressures.

What is the treatment for PPHN?

Treatment includes oxygen therapy, mechanical ventilation, inhaled nitric oxide (iNO), extracorporeal membrane oxygenation (ECMO), fluid and electrolyte management, and pharmacological therapy.

Contact Us Now For Persistent Pulmonary Hypertension And Other Birth-Related Injuries

Is your child struggling with Persistent Pulmonary Hypertension or any other birth injury? Our experienced birth injury lawyers are dedicated to helping families like yours. Contact us now at  (312) 598-0930 to schedule a consultation. Take the first step toward seeking justice and compensation for your child’s injuries.

Interesting Reads:

Torticollis Birth Injury

Hypoxic Ischemic Encephalopathy

Infant Subconjunctival Hemorrhage

The post Persistent Pulmonary Hypertension of Newborn (PPHN) appeared first on Phillips Law Offices.